Skip to main content
915 TLDR
Health
1 read

Hantavirus Cases Rise Among Passengers Returning to U.S. from Cruise

KVIA••ABC News
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

Read Original

AI Summary

The hantavirus outbreak aboard the MV Hondius cruise ship has escalated, with nine confirmed and probable cases reported, including two fatalities. Among the passengers, 17 U.S. citizens are returning home, with one confirmed positive case of hantavirus. This individual will be taken to the Nebraska Biocontainment Unit for treatment upon arrival. The situation highlights the ongoing health risks associated with the virus, emphasizing the need for vigilance among travelers and health authorities.

Key Details: • Nine confirmed and probable hantavirus cases reported from the cruise ship. • Two fatalities linked to the outbreak. • One American passenger will be transported to the Nebraska Biocontainment Unit.

health travel cruise outbreak hantavirus

People & Organizations

Department of Health and Human ServicesNebraskaTenerife

Related Articles

KVIA•Jun 20

US Health Department Proposes Changes to Testosterone Therapy Guidelines

The US Department of Health and Human Services (HHS) is advocating for revisions to the labeling of testosterone replacement therapies for men, aiming to improve access and clarify safety information. Proposed changes include removing the assertion that the effectiveness of testosterone therapy is unproven for age-related low testosterone and updating warnings about prostate cancer risks. HHS Secretary Robert F. Kennedy Jr. emphasized that these updates will aid informed medical decisions for millions of men. Despite the proposed changes, experts urge patients to discuss therapy options thoroughly with their doctors, as the updates do not equate to a blanket recommendation for all men. The changes are seen as a necessary evolution in understanding testosterone therapy's safety and benefits.

Health
1 min read
KTSM•Jun 20

Comparative Study Reveals Effectiveness of Popular Weight Loss Medications

A recent meta-analysis evaluated the effectiveness of three GLP-1 medications: tirzepatide (Zepbound, Mounjaro), semaglutide (Wegovy, Ozempic), and liraglutide (Saxenda, Victoza). This study is significant as it provides insights for healthcare providers and patients in El Paso seeking effective weight management solutions. The findings could influence treatment decisions and accessibility of these medications, which are becoming increasingly popular for weight loss. As obesity rates continue to rise, understanding which medication offers the best results is crucial for public health.

Health
1 min read
KTSM•Jun 20

Comparative Study Evaluates Effectiveness of GLP-1 Medications for Weight Loss

A recent meta-analysis has compared the effectiveness of three GLP-1 medications: tirzepatide, semaglutide, and liraglutide. Tirzepatide, marketed as Zepbound and Mounjaro, emerged as the most effective option among the three, which also include semaglutide (Wegovy and Ozempic) and liraglutide (Saxenda and Victoza). This study is significant as it provides insights for healthcare providers and patients seeking effective weight loss solutions. Understanding which medication works best can help in making informed decisions regarding obesity treatment options.

Health
1 min read
KTSM•Jun 20

Weight Training Linked to Increased Longevity, New Study Reveals

A recent study has highlighted the positive impact of weight training on longevity, indicating that engaging in 90 to 120 minutes of strength training each week can significantly enhance lifespan. This research underscores the importance of physical fitness, particularly resistance exercises, in promoting health and well-being. As residents of El Paso consider their fitness routines, this study serves as a reminder of the potential long-term benefits of incorporating weightlifting into their weekly schedules.

Health
1 min read